High-dose-rate interstitial brachytherapy in early stage oral tongue cancer – 15 year experience from a tertiary care institute

PURPOSE: To determine outcomes of interstitial high-dose-rate brachytherapy (HDR-BT) in patients with early stage oral tongue cancer. MATERIAL AND METHODS: Ninety-two patients with stage I and II oral tongue cancer were treated with HDR-BT between 1999 and 2014: brachytherapy alone = 62 (67.4%), and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bansal, Anshuma, Ghoshal, Sushmita, Oinam, Arun S, Sharma, Suresh Chander, Dhanireddy, Bhaswanth, Kapoor, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793073/
https://www.ncbi.nlm.nih.gov/pubmed/26985198
http://dx.doi.org/10.5114/jcb.2016.58082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793073/
https://www.ncbi.nlm.nih.gov/pubmed/26985198
http://dx.doi.org/10.5114/jcb.2016.58082

Ejemplares similares